Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors

OBJECTIVES: It remains controversial whether sarcopenia has any significant impact on the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) or immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). Therefore, in this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Jiahua, Yang, Ningjing, Xiao, Ling, Nie, Xinyu, Xiong, Jing, Liu, Yudi, Zhang, Min, Zhang, Hangyue, Tang, Cunhan, Pan, Shiyi, Liang, Long, Bai, Hansong, Li, Churong, Kuang, Hao, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031770/
https://www.ncbi.nlm.nih.gov/pubmed/36969820
http://dx.doi.org/10.3389/fnut.2023.1113875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031770/
https://www.ncbi.nlm.nih.gov/pubmed/36969820
http://dx.doi.org/10.3389/fnut.2023.1113875

Ejemplares similares